When should a diagnosis of influenza be considered in adults requiring intensive care unit admission? Results of population-based active surveillance in Toronto

Critical Care

Volumn 15, Issue 4, 2011, Pages

  Kuster, Stefan P ^a   Katz, Kevin C ^b,c   Blair, Joanne ^d   Downey, James ^e   Drews, Steven J ^f   Finkelstein, Sandy ^g   Fowler, Rob ^b,h   Green, Karen ^a   Gubbay, Jonathan ^b,d   Hassan, Kazi ^a   Lapinsky, Stephen E ^a,b   Mazzulli, Tony ^a,b   McRitchie, Donna ^b,c   Pataki, Janos ⁱ   Plevneshi, Agron ^a   Powis, Jeff ^b,e   Rose, David ^g   Sarabia, Alicia ⁱ   Simone, Carmine ^e   Simor, Andrew ^b,h   McGeer, Allison ^a,b   more..

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c NORTH YORK GENERAL HOSPITAL   (Canada)

^d PUBLIC HEALTH ONTARIO   (Canada)

^e TORONTO EAST GENERAL HOSPITAL   (Canada)

^f UNIVERSITY OF CALGARY   (Canada)

^g SCARBOROUGH HOSPITAL   (Canada)

^h SUNNYBROOK RESEARCH INSTITUTE   (Canada)

ⁱ CREDIT VALLEY HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2009 H1N1 INFLUENZA; ACUTE RESPIRATORY TRACT DISEASE; ADULT; AGED; ARTICLE; BODY TEMPERATURE; CANADA; DISEASE SURVEILLANCE; EMERGENCY CARE; FEMALE; FEVER; HEART DISEASE; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; INFLUENZA; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; PATIENT IDENTIFICATION; PNEUMONIA; PREDICTIVE VALUE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SEASONAL INFLUENZA; THROAT CULTURE; ADOLESCENT; DECISION MAKING; HEALTH SURVEY; HOSPITAL; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS B; INTENSIVE CARE UNIT; ISOLATION AND PURIFICATION; MIDDLE AGED; PATHOPHYSIOLOGY; STATISTICAL MODEL; VIROLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DECISION MAKING; FEMALE; HOSPITALS, URBAN; HUMANS; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA, HUMAN; INTENSIVE CARE UNITS; LOGISTIC MODELS; MALE; MIDDLE AGED; ONTARIO; PATIENT ADMISSION; POPULATION SURVEILLANCE; YOUNG ADULT;

EID: 79960657056     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc10331     Document Type: Article

References (37)

1. Webb SA, Pettilä V, Seppelt I, Bellomo R, Bailey M, Cooper DJ, Cretikos M, Davies AR, Finfer S, Harrigan PW, Hart GK, Howe B, Iredell JR, McArthur C, Mitchell I, Morrison S, Nichol AD, Paterson DL, Peake S, Richards B, Stephens D, Turner A, Yung M. ANZIC Influenza Investigators Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med 2009, 361:1925-1934. ANZIC Influenza Investigators.
2. Kumar A, Zarychanski R, Pinto R, Cook DJ, Marshall J, Lacroix J, Stelfox T, Bagshaw S, Choong K, Lamontagne F, Turgeon AF, Lapinsky S, Ahern SP, Smith O, Siddiqui F, Jouvet P, Khwaja K, McIntyre L, Menon K, Hutchison J, Hornstein D, Joffe A, Lauzier F, Singh J, Karachi T, Wiebe K, Olafson K, Ramsey C, Sharma S, Dodek P, Meade M, Hall R, Fowler RA, . Canadian Critical Care Trials Group H1N1 Collaborative Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 2009, 302:1872-1879. 10.1001/jama.2009.1496, 19822627, Canadian Critical Care Trials Group H1N1 Collaborative.
3. Domínguez-Cherit G, Lapinsky SE, Macias AE, Pinto R, Espinosa-Perez L, de la Torre A, Poblano-Morales M, Baltazar-Torres JA, Bautista E, Martinez A, Martinez MA, Rivero E, Valdez R, Ruiz-Palacios G, Hernández M, Stewart TE, Fowler RA. Critically Ill patients with 2009 influenza A(H1N1) in Mexico. JAMA 2009, 302:1880-1887. 10.1001/jama.2009.1536, 19822626.
4. Farias JA, Fernández A, Monteverde E, Vidal N, Arias P, Montes MJ, Rodríguez G, Allasia M, Ratto ME, Jaén R, Meregalli C, Fiquepron K, Calvo AR, Siaba A, Albano L, Poterala R, Neira P, Esteban A. Critically ill infants and children with influenza A (H1N1) in pediatric intensive care units in Argentina. Intensive Care Med 2010, 36:1015-1022. 10.1007/s00134-010-1853-1, 20237757.
5. Yang P, Deng Y, Pang X, Shi W, Li X, Tian L, Zhang Y, Wang X, Huang F, Raina MC, Wang Q. Severe, critical and fatal cases of 2009 H1N1 influenza in China. J Infect 2010, 61:277-283. 10.1016/j.jinf.2010.07.010, 20670649.
6. WHO Guidelines for Pharmacological Management of Pandemic Influenza A(H1N1) 2009 and Other Influenza Viruses. Revised February 2010. Part I: Recommendations. , http://www.who.int/csr/resources/publications/swineflu/h1n1_guidelines_pharmaceutical_mngt.pdf
7. CDC H1N1 Flu: Updated Interim Recommendations for the Use of Antiviral Medications in the Treatment and Prevention of Influenza for the 2009-2010 Season. , http://www.cdc.gov/h1n1flu/recommendations.htm#c
8. Clinical Guidance for the Management of Influenza-Like Illness in the Context of Pandemic H1N1 Influenza Virus in Adult Intensive Care Units. , http://www.canadiancriticalcare.org/ICU_Guidelines_English.pdf
9. McGeer AJ. Diagnostic testing or empirical therapy for patients hospitalized with suspected influenza: what to do?. Clin Infect Dis 2009, 48(Suppl 1):S14-S19.
10. Kuster SP, Drews S, Green K, Blair J, Davis I, Downey J, Fowler R, Katz K, Lapinsky S, McRitchie D, Pataki J, Powis J, Rose D, Sarabia A, Simone C, Simor A, Stewart T, McGeer A. Epidemiology of influenza-associated hospitalization in adults, Toronto, 2007/8. Eur J Clin Microbiol Infect Dis 2010, 29:835-843. 10.1007/s10096-010-0935-x, 2889286, 20428910.
11. Daneman N, McGeer A, Green K, Low DE. Macrolide resistance in bacteremic pneumococcal disease: implications for patient management. Clin Infect Dis 2006, 43:432-438. 10.1086/505871, 16838231.
12. McGeer A, Green KA, Plevneshi A, Shigayeva A, Siddiqi N, Raboud J, Low DE. Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin Infect Dis 2007, 45:1568-1575. 10.1086/523584, 18190317.
13. Vanderkooi OG, Low DE, Green K, Powis JE, McGeer A. Predicting antimicrobial resistance in invasive pneumococcal infections. Clin Infect Dis 2005, 40:1288-1297. 10.1086/429242, 15825031.
14. Harrell FE. Overview of maximum likelihood estimation. Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis 2001, 179-214. New York: Springer.
15. FluWatch Weekly Reports Archive 2007-2008 Season. , http://www.phac-aspc.gc.ca/fluwatch/07-08/index-eng.php
16. FluWatch Weekly Reports Archive 2008-2009 Season. , http://www.phac-aspc.gc.ca/fluwatch/08-09/index-eng.php
17. FluWatch Weekly Reports Archive 2009-2010 Season. , http://www.phac-aspc.gc.ca/fluwatch/09-10/index-eng.php
18. Falagas ME, Koletsi PK, Vouloumanou EK, Rafailidis PI, Kapaskelis AM, Rello J. Effectiveness and safety of neuraminidase inhibitors in reducing influenza complications: a meta-analysis of randomized controlled trials. J Antimicrob Chemother 2010, 65:1330-1346. 10.1093/jac/dkq158, 20488984.
19. Jefferson T, Demicheli V, Rivetti D, Jones M, Di Pietrantonj C, Rivetti A. Antivirals for influenza in healthy adults: systematic review. Lancet 2006, 367:303-313. 10.1016/S0140-6736(06)67970-1, 16443037.
20. Moscona A. Neuraminidase inhibitors for influenza. N Engl J Med 2005, 353:1363-1373. 10.1056/NEJMra050740, 16192481.
21. Yu H, Liao Q, Yuan Y, Zhou L, Xiang N, Huai Y, Guo X, Zheng Y, van Doorn HR, Farrar J, Gao Z, Feng Z, Wang Y, Yang W. Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China. BMJ 2010, 341:c4779. 10.1136/bmj.c4779, 2947622, 20876641.
22. Harper SA, Bradley JS, Englund JA, File TM, Gravenstein S, Hayden FG, McGeer AJ, Neuzil KM, Pavia AT, Tapper ML, Uyeki TM, Zimmerman RK, . Expert Panel of the Infectious Diseases Society of America Seasonal influenza in adults and children-diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2009, 48:1003-1032. 10.1086/598513, 19281331, Expert Panel of the Infectious Diseases Society of America.
23. Aoki FY, Macleod MD, Paggiaro P, Carewicz O, El Sawy A, Wat C, Griffiths M, Waalberg E, Ward P, . IMPACT Study Group Early administration of oral oseltamivir increases the benefits of influenza treatment. J Antimicrob Chemother 2003, 51:123-129. 10.1093/jac/dkg007, 12493796, IMPACT Study Group.
24. Baccam P, Beauchemin C, Macken CA, Hayden FG, Perelson AS. Kinetics of influenza A virus infection in humans. J Virol 2006, 80:7590-7599. 10.1128/JVI.01623-05, 1563736, 16840338.
25. Falagas ME, Vouloumanou EK, Baskouta E, Rafailidis PI, Polyzos K, Rello J. Treatment options for 2009 H1N1 influenza: evaluation of the published evidence. Int J Antimicrob Agents 2010, 35:421-430. 10.1016/j.ijantimicag.2010.01.006, 20185273.
26. Gillissen A, Hoffken G. Early therapy with the neuraminidase inhibitor oseltamivir maximizes its efficacy in influenza treatment. Med Microbiol Immunol 2002, 191:165-168. 10.1007/s00430-002-0139-9, 12458353.
27. Hayden FG, Osterhaus AD, Treanor JJ, Fleming DM, Aoki FY, Nicholson KG, Bohnen AM, Hirst HM, Keene O, Wightman K. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group. N Engl J Med 1997, 337:874-880. 10.1056/NEJM199709253371302, 9302301.
28. Ling LM, Chow AL, Lye DC, Tan AS, Krishnan P, Cui L, Win NN, Chan M, Lim PL, Lee CC, Leo YS. Effects of early oseltamivir therapy on viral shedding in 2009 pandemic influenza A (H1N1) virus infection. Clin Infect Dis 2010, 50:963-969. 10.1086/651083, 20180701.
29. Cunney RJ, Bialachowski A, Thornley D, Smaill FM, Pennie RA. An outbreak of influenza A in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2000, 21:449-454. 10.1086/501786, 10926394.
30. Oliveira EC, Lee B, Colice GL. Influenza in the intensive care unit. J Intensive Care Med 2003, 18:80-91. 10.1177/0885066602250368, 15189654.
31. Salgado CD, Farr BM, Hall KK, Hayden FG. Influenza in the acute hospital setting. Lancet Infect Dis 2002, 2:145-155. 10.1016/S1473-3099(02)00221-9, 11944184.
32. Guidance: Infection Prevention and Control Measures for Healthcare Workers in Acute Care and Long-term Care Settings: Seasonal Influenza. , http://www.phac-aspc.gc.ca/nois-sinp/guide/pdf/ac-sa-eng.pdf
33. Centers for Disease Control and Prevention Guidelines and Recommendations: Infection Control Guidance for the Prevention and Control of Influenza in Acute-Care Facilities. Centers for Disease Control and Prevention., http://www.cdc.gov/flu/professionals/infectioncontrol/pdf/acutecare.pdf
34. Uyeki TM. Influenza diagnosis and treatment in children: a review of studies on clinically useful tests and antiviral treatment for influenza. Pediatr Infect Dis J 2003, 22:164-177.
35. Hurt AC, Alexander R, Hibbert J, Deed N, Barr IG. Performance of six influenza rapid tests in detecting human influenza in clinical specimens. J Clin Virol 2007, 39:132-135. 10.1016/j.jcv.2007.03.002, 17452000.
36. Rahman M, Kieke BA, Vandermause MF, Mitchell PD, Greenlee RT, Belongia EA. Performance of Directigen flu A+B enzyme immunoassay and direct fluorescent assay for detection of influenza infection during the 2004-2005 season. Diagn Microbiol Infect Dis 2007, 58:413-418. 10.1016/j.diagmicrobio.2007.03.011, 17509800.
37. Rothberg MB, Haessler SD, Brown RB. Complications of viral influenza. Am J Med 2008, 121:258-264. 10.1016/j.amjmed.2007.10.040, 18374680.